Now, with industry having dropped the number of trials going on in India by more than half, many are wondering whether the government is regretting its fairly hard-line stance of last year. Speaking after the inauguration of a new Baxter global research center in Syngene, Union Health Minister Ghulam Nabi Azad said,
“The industry has complained that the regulations are too stringent, but there have also been complaints by parliamentarians, NGOs and others that they are too lax, which the Supreme Court had taken note of....We are happy with the current balance between the different interests, but industry also needs to be happy....Pointing out the decline in the number of trials, he added: "While we are interested in the matter of patient safety, we also want to make sure that innovation is not hampered.”
Many in the press seem to be taking this as a sign that the law will be relaxed. Stay tuned!